Home > Boards > US Listed > Medical - Drugs > AcelRx Pharmaceuticals, Inc. (ACRX)

Sure it has it's positive days ahead but

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Lenard Member Profile
 
Followed By 35
Posts 3,119
Boards Moderated 0
Alias Born 11/01/11
160x600 placeholder
AcelRx added to the Russell 2000® and 3000® indexes PR Newswire (US) - 7/1/2019 2:00:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 7:06:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 7:05:26 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 7:03:55 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 7:03:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 7:01:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 6:59:29 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/25/2019 4:50:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/6/2019 6:06:27 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/3/2019 7:11:14 AM
AcelRx announces the closing of a $25 million senior secured debt facility PR Newswire (US) - 6/3/2019 7:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 5/14/2019 6:11:56 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 5/14/2019 6:11:08 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/9/2019 8:56:02 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/9/2019 8:53:27 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/8/2019 4:06:39 PM
AcelRx Pharmaceuticals Reports First Quarter 2019 Financial Results PR Newswire (US) - 5/8/2019 4:01:00 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 5/3/2019 5:06:22 PM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 4/30/2019 6:34:09 AM
AcelRx to announce first quarter 2019 results and provide an update on the company's business on Wednesday, May 8th, 2019 PR Newswire (US) - 4/25/2019 4:05:00 PM
AcelRx Pharmaceutical's pooled safety results for sufentanil sublingual tablets (DSUVIA) selected for presentation at 44th An... PR Newswire (US) - 4/11/2019 4:37:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/12/2019 2:17:20 PM
AcelRx Pharmaceuticals to Present at Oppenheimer & Co. Inc. 29th Annual Healthcare Conference PR Newswire (US) - 3/11/2019 4:01:00 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 3/7/2019 5:58:54 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/7/2019 5:58:53 PM
Lenard   Saturday, 03/09/19 01:17:28 AM
Re: None
Post # of 1167 
Sure it has it's positive days ahead but until it doubles it will be all over the place on the slightest rumor bad or good mostly false hopes until hard numbers come in. The conference call showed even if they are on track they are not going to cause any reason for excitement, sometimes I wonder if they are running a private company instead of the public one it is supposed to be

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist